Pembrolizumab-induced myositis

Joint Bone Spine. 2022 Nov;89(6):105414. doi: 10.1016/j.jbspin.2022.105414. Epub 2022 May 27.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Humans
  • Myositis* / chemically induced
  • Myositis* / diagnosis

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized